Biomarkers Market Size | Global Industry Trends, Key Players and Forecast Report 2024

Press Release

A biological marker, commonly known as a biomarker, measures and evaluates biological and pathogenic processes. It also measures pharmacological responses to a therapeutic intervention. Biomarkers are used in predictions, cause, diagnosis, progression, regression and outcome of various diseases. Biomarkers can be specific cell, molecules, genes, gene products, enzymes, hormones, complex organ functions, and general characteristic changes in biological structure.

Based on the discovery technologies the global biomarkers market can be broadly segmented as imaging technologies, OMICS technologies for biomarkers discovery, and bioinformatics. Further the imaging technologies can be further segmented as Positron Emission Tomography (PET), single-photon emission computed tomography (SPECT), ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT). OMICS technologies for biomarkers discovery market can further be segmented as proteomics, genomics, transcriptomics, and metabolomics. The bioinformatics segment of biomarker market can further segmented as cluster analysis, statistical analysis, cell signal pathways, computer aided design, data mining, and protein interaction maps.

Request for report sample at: http://bit.ly/2rkHYA2

Based on the various services the global biomarker market can be segmented as clinical, and bioinformatics. Clinical segment can be further classified as sample preparation, assay development, and biomarkers validation & testing. Based on the various applications of biomarkers the global biomarkers market can be bifurcated as drug discovery & development, personalized medicine, and molecular diagnostics. The clinical trials segment can be further bifurcated as preclinical development phase I drug development, phase II drug development, phase III drug development, and phase IV drug development.

Based on the various diseases the global biomarkers market can be segmented as an oncology biomarkers market, cardiology biomarkers market, neurology biomarkers market, other indications biomarkers market, HIV, renal failure, arthritis, tuberculosis, and diabetes.

Some of the major players operating in the global biomarkers market include, Abbott Laboratories, Affymetrix Inc., Agilent Technologies Inc., Dickinson and Company, Becton, Celera Corporation., Epigenomics AG., Bruker Corporation, DiagnoCure Inc., GE Healthcare, Siemens AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Clarient Inc., hermo Fisher Scientific, Inc., Epistem Ltd., and Aushon BioSystem Inc.

This post was originally published on Financial Sector

Comments are closed.